Ligand-independent activation of MET through IGF-1/IGF-1R signaling

Targeting Constitutively Activated β 1 Integrins Inhibits Prostate Cancer Metastasis

(2013) Yu-Chen Lee et al.   MOLECULAR CANCER RESEARCH

Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607

(2012) Yao Dai et al.   BMC CANCER

c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential

(2012) Xinqi Wu et al.   MELANOMA RESEARCH

The Primacy of β1 Integrin Activation in the Metastatic Cascade

(2012) Hisashi Kato et al.   PLoS One

Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways

(2012) Farshid Dayyani et al.   PLoS One

Dasatinib combined with docetaxel for castration-resistant prostate cancer

(2011) John C. Araujo et al.   CANCER

Development of c-MET pathway inhibitors

(2011) Xiangdong Liu et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials

(2011) Andreas Varkaris et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy

(2011) Marie Brevet et al.   Journal of Thoracic Oncology

HGF-independent potentiation of EGFR action by c-Met

(2011) A M Dulak et al.   ONCOGENE

Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor

(2010) Shibnath Ghatak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting the HGF/c-Met Axis: State of Play

(2010) T. A. Yap et al.   MOLECULAR CANCER THERAPEUTICS

MET signalling: principles and functions in development, organ regeneration and cancer

(2010) Livio Trusolino et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study

(2009) Primo N. Lara et al.   ANTI-CANCER DRUGS

Targeting of Bone-Derived Insulin-Like Growth Factor-II by a Human Neutralizing Antibody Suppresses the Growth of Prostate Cancer Cells in a Human Bone Environment

(2009) T. Kimura et al.   CLINICAL CANCER RESEARCH

Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer

(2009) J. P. Eder et al.   CLINICAL CANCER RESEARCH

Crosstalk in Met receptor oncogenesis

(2009) Andrea Z. Lai et al.   TRENDS IN CELL BIOLOGY

Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells

(2008) D. L. Shattuck et al.   CANCER RESEARCH

Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model

(2008) S. I. Park et al.   CANCER RESEARCH

Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor

(2008) T. E. Reznik et al.   MOLECULAR CANCER RESEARCH

Unknown

(2008) Efstathia Papageorgiou et al.   MOLECULAR MEDICINE